Events

Poland and Taiwan Turn Biotech Dialogue into Partnership at BIO Asia–Taiwan 2026

  Poland and Taiwan moved to strengthen their biotechnology relationship at the Poland–Taiwan Biotechnology Forum, held on 17 July during BIO A...

 July 20, 2026 | News

Canada and Taiwan Build New Bridges Across AI, Advanced Therapeutics and Precision Health

  As biotechnology increasingly converges with artificial intelligence, advanced therapeutics and data-driven healthcare, the next generation of inno...

 July 20, 2026 | News

Why Korea, Why Now? Korean Biotech Looks to Taiwan as Asia’s Next Partnership Frontier

Korea’s biotechnology industry is entering a new phase of global ambition. Having established significant capabilities across biopharmaceutical manuf...

 July 20, 2026 | News

Japan Looks Beyond Its Borders to Build the Next Generation of Biotech Innovation

Japan’s biotechnology sector is entering a new phase in which scientific strength alone may no longer determine success. As drug development becomes ...

 July 20, 2026 | News

Malaysia Positions Biotechnology as a Bridge Between Asian Innovation and Global Markets

  As Asia’s biotechnology sector moves from scientific capability towards commercial scale, Malaysia is positioning itself as an increasingly i...

 July 20, 2026 | News

The Netherlands Positions Itself as Europe’s Gateway for Life Sciences Innovation

For biotechnology companies looking towards Europe, the opportunity is considerable—but so is the complexity. Accessing one of the world’s larg...

 July 20, 2026 | News

Hong Kong Makes Its Case as Asia’s Biotech Super-Connector: Capital, Regulation and Scale Converge

  Hong Kong is seeking to redefine its place in the global life sciences economy. No longer content to be viewed primarily as a financial gateway int...

 July 20, 2026 | News

Australia and Taiwan Build a Faster Clinical Bridge for Global Biotech Development

  As biotechnology companies face mounting pressure to move promising science into human studies faster, the relationship between Australia and Taiwa...

 July 20, 2026 | News

Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026

BIO Asia-Taiwan 2026 opens July 16 at the Taipei Nangang Exhibition Center and runs through July 19. Creative Life Science (7837) is showcasing its upstrea...

 July 20, 2026 | News

Lilly's Jaypirca Combination Cuts Disease Progression Risk by 45% in Relapsed CLL Phase 3 Trial

BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the...

 June 16, 2026 | News

Waters Introduces Cyclic IMS P20 to Advance Structural and Spatial Omics Research

Waters Corporation has introduced the Cyclic IMS P20 Mass Spectrometer, a next generation structural and spatial omics platform designed to provide researc...

 June 04, 2026 | News

Leads Biolabs Secures China Phase III Approval For Opamtistomig In First Line EP NEC Treatment

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific antibod...

 May 20, 2026 | News

Sino Biological Europe GmbH Launches EliteScience VIP Partnership Program For European Researchers

Sino Biological Europe GmbH, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently launched its El...

 May 13, 2026 | News

Genexine Advances First In Class SOX2 Targeting BioPROTAC GX BP1 With Strong Preclinical Anti Tumour Data

Genexine, Inc. (KOSDAQ: 095700), a clinical-stage biotechnology company,  announced new preclinical data for its SOX2-targeting bioPROTAC candidate, G...

 May 04, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close